Literature DB >> 24309995

The relationship between serum mannose-binding lectin levels and acute ischemic stroke risk.

Zhen-Yu Wang1, Zhong-Ren Sun, Li-Ming Zhang.   

Abstract

Complement activation and inflammation have been suggested in the pathogenesis of stroke, mannose-binding lectin (MBL) were found to have roles during the process. The aim of this study was to investigate the relationship between acute ischemic stroke (AIS) and serum MBL levels in Chinese population. From January 1 to June 30 2013, all patients with first-ever AIS were recruited to participate in the study. Serum MBL levels and routine test were examined. The National Institutes of Health Stroke Scale (NIHSS) score was assessed on admission blinded to MBL levels. During the inclusion period, 148 patients with AIS were registered and completed study. The results indicated that the serum MBL levels were significantly (p < 0.0001) higher in acutely ischemic stroke patients as compared to normal controls [1,332; interquartile range (IQR) 996-2,134 μg/L and 897; IQR 678-1,100 μg/L, respectively]. There was a correlation between serum levels of MBL and NIHSS score [r (spearman) = 0.608, p < 0.0001). In multivariate analysis, serum MBL as a continuous variable was associated with an increased risk of AIS, after adjustment for above possible confounders (OR 1.002, 95 % CI 1.001-1.008; p < 0.0001). These results indicated that elevated MBL levels could be considered as an independent stroke risk factor in Chinese population, suggesting a role of MBL and the lectin pathway of complement activation in the pathogenesis of stroke.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24309995     DOI: 10.1007/s11064-013-1214-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  34 in total

1.  The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion.

Authors:  Rodney K Chan; Shahrul I Ibrahim; Kazue Takahashi; Edwin Kwon; Michael McCormack; Alan Ezekowitz; Michael C Carroll; Francis D Moore; William G Austen
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood.

Authors:  A Koch; M Melbye; P Sørensen; P Homøe; H O Madsen; K Mølbak; C H Hansen; L H Andersen; G W Hahn; P Garred
Journal:  JAMA       Date:  2001-03-14       Impact factor: 56.272

3.  Complement activation after oxidative stress: role of the lectin complement pathway.

Authors:  C D Collard; A Väkevä; M A Morrissey; A Agah; S A Rollins; W R Reenstra; J A Buras; S Meri; G L Stahl
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

4.  Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis.

Authors:  Walter S Speidl; Markus Exner; Jasmin Amighi; Stefan P Kastl; Gerlinde Zorn; Gerald Maurer; Oswald Wagner; Kurt Huber; Erich Minar; Johann Wojta; Martin Schillinger
Journal:  Eur Heart J       Date:  2005-05-25       Impact factor: 29.983

5.  Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Robert A Matthijsen; Menno P J de Winther; Dian Kuipers; Ingeborg van der Made; Christian Weber; M Veronica Herias; Marion J J Gijbels; Wim A Buurman
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

6.  The effect of mannan-binding lectin variant alleles on coronary artery reactivity in healthy young men.

Authors:  Janne Aittoniemi; Yue-Mei Fan; Reijo Laaksonen; Tuula Janatuinen; Risto Vesalainen; Pirjo Nuutila; Juhani Knuuti; Janne Hulkkonen; Mikko Hurme; Terho Lehtimäki
Journal:  Int J Cardiol       Date:  2004-11       Impact factor: 4.164

7.  Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study.

Authors:  Lyle G Best; Michael Davidson; Kari E North; Jean W MacCluer; Ying Zhang; Elisa T Lee; Barbara V Howard; Susan DeCroo; Robert E Ferrell
Journal:  Circulation       Date:  2004-01-19       Impact factor: 29.690

8.  Measurements of acute cerebral infarction: lesion size by computed tomography.

Authors:  T Brott; J R Marler; C P Olinger; H P Adams; T Tomsick; W G Barsan; J Biller; R Eberle; V Hertzberg; M Walker
Journal:  Stroke       Date:  1989-07       Impact factor: 7.914

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women.

Authors:  Tymen T Keller; Sander I van Leuven; Marijn C Meuwese; Nicholas J Wareham; Robert Luben; Erik S Stroes; C Erik Hack; Marcel Levi; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-10       Impact factor: 8.311

View more
  11 in total

1.  Elevated Serum Mannose-Binding Lectin Levels Are Associated with Poor Outcome After Acute Ischemic Stroke in Patients with Type 2 Diabetes.

Authors:  Fang-Yu Song; Meng-Hai Wu; Li-Hua Zhu; Zhi-Qiang Zhang; Qin-De Qi; Chang-Li Lou
Journal:  Mol Neurobiol       Date:  2014-10-25       Impact factor: 5.590

2.  Prognostic value of serum 25-hydroxyvitamin D in patients with stroke.

Authors:  Yan Wang; Hui Ji; Ying Tong; Zhuo-bo Zhang
Journal:  Neurochem Res       Date:  2014-05-01       Impact factor: 3.996

Review 3.  Injury site-specific targeting of complement inhibitors for treating stroke.

Authors:  Ali Alawieh; Stephen Tomlinson
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

4.  Prognostic value of mannose-binding lectin: 90-day outcome in patients with acute ischemic stroke.

Authors:  Zhi-Guo Zhang; Chao Wang; Jing Wang; Zhuo Zhang; Yan-Long Yang; Li Gao; Xing-Ye Zhang; Tao Chang; Guo-Dong Gao; Li-Hong Li
Journal:  Mol Neurobiol       Date:  2014-04-02       Impact factor: 5.590

5.  High Mannose-Binding Lectin Serum Levels Are Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes.

Authors:  Qian Huang; Guilian Shang; Haohua Deng; Jie Liu; Yan Mei; Yancheng Xu
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

6.  MicroRNAs regulating cluster of differentiation 46 (CD46) in cardioembolic and non-cardioembolic stroke.

Authors:  Jun Rong Tan; Kay Sin Tan; Fung Lin Yong; Arunmozhiarasi Armugam; Chee Woon Wang; Kandiah Jeyaseelan; Peter Tsun-Hon Wong
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

7.  Mannose-Binding Lectin: A Potential Therapeutic Candidate against Candida Infection.

Authors:  Noha M Hammad; Nissreen E El Badawy; Hamed A Ghramh; Laila M Al Kady
Journal:  Biomed Res Int       Date:  2018-05-02       Impact factor: 3.411

8.  Lectin complement pathway initiators after subarachnoid hemorrhage - an observational study.

Authors:  Jeppe Sillesen Matzen; Charlotte Loumann Krogh; Julie Lyng Forman; Peter Garred; Kirsten Møller; Søren Bache
Journal:  J Neuroinflammation       Date:  2020-11-12       Impact factor: 8.322

Review 9.  Mannan-binding lectin in cardiovascular disease.

Authors:  Izabela Pągowska-Klimek; Maciej Cedzyński
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

10.  Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke.

Authors:  R Zangari; E R Zanier; G Torgano; A Bersano; S Beretta; E Beghi; B Casolla; N Checcarelli; S Lanfranconi; A Maino; C Mandelli; G Micieli; F Orzi; E Picetti; M Silvestrini; N Stocchetti; B Zecca; P Garred; M G De Simoni
Journal:  J Neuroinflammation       Date:  2016-01-20       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.